# Steven E. Nissen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/steven-e-nissen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,647 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 94 |
| i10-index | 315 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5040589473 |
| ORCID iD | https://orcid.org/0000-0002-7231-6464 |
| Works | 668 |

## Researcher papers

- [Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/liraglutide-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes](https://scholariq.org/papers/bariatric-surgery-versus-intensive-medical-therapy-for-diabetes-5-year-outcomes/)
- [Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes](https://scholariq.org/papers/alogliptin-after-acute-coronary-syndrome-in-patients-with-type-2-diabetes/)
- [Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes](https://scholariq.org/papers/bariatric-surgery-versus-intensive-medical-therapy-for-diabetes-3-year-outcomes/)
- [Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.](https://scholariq.org/papers/pioglitazone-and-risk-of-cardiovascular-events-in-patients-with-type-2-diabetes/)
- [Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients](https://scholariq.org/papers/bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/)
- [2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials](https://scholariq.org/papers/2017-cardiovascular-and-stroke-endpoint-definitions-for-clinical-trials/)
- [2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials](https://scholariq.org/papers/2014-acc-aha-key-data-elements-and-definitions-for-cardiovascular-endpoint/)
- [2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials](https://scholariq.org/papers/2014-acc-aha-key-data-elements-and-definitions-for-cardiovascular-endpoint-2/)
- [Cardiovascular Safety of Testosterone-Replacement Therapy](https://scholariq.org/papers/cardiovascular-safety-of-testosterone-replacement-therapy/)
- [Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy](https://scholariq.org/papers/myosin-inhibition-in-patients-with-obstructive-hypertrophic-cardiomyopathy/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.